Xencor Lands $69,850,000 New Funding

  • Feed Type
  • Date
    12/3/2013
  • Company Name
    Xencor
  • Mailing Address
    111 West Lemon Avenue Monrovia, CA 91016
  • Company Description
    Xencor (NASDAQ: XNCR) is selectively designing next-generation protein drug candidates with improved selectivity, efficacy and safety.
  • Website
    http://www.xencor.com
  • Transaction Type
    IPO
  • Transaction Amount
    $69,850,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms